CLINICAL_TRIALS
trial_result
· 2026-03-24
Clinical Trial Update: Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action [Phase 4]
Summary
A Phase 4 trial update provides new insights into migraine pathophysiology and the mechanism of action of galcanezumab, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Beth Israel Deaconess Medical Center | Conditions: Chronic Migraine | Phase 4 | Status: COMPLETED | Results posted: 2026-03-24